Singular Genomics Systems (NASDAQ:OMIC) Trading 0.4% Higher – Time to Buy?

Singular Genomics Systems, Inc. (NASDAQ:OMIC) shot up 0.4% during mid-day trading on Tuesday . The stock traded as high as $23.00 and last traded at $22.97. 6,086 shares changed hands during mid-day trading, a decline of 83% from the average session volume of 34,845 shares. The stock had previously closed at $22.88.

Singular Genomics Systems Stock Performance

The stock has a market capitalization of $57.33 million, a PE ratio of -0.61 and a beta of 1.51. The company has a quick ratio of 8.04, a current ratio of 8.77 and a debt-to-equity ratio of 0.05. The stock has a fifty day moving average of $14.33 and a 200-day moving average of $11.10.

Singular Genomics Systems (NASDAQ:OMIC) last announced its quarterly earnings data on Tuesday, August 13th. The company reported ($8.57) earnings per share (EPS) for the quarter, beating the consensus estimate of ($8.86) by $0.29. The business had revenue of $0.74 million during the quarter, compared to analysts’ expectations of $0.40 million. Singular Genomics Systems had a negative return on equity of 54.66% and a negative net margin of 3,375.72%.

Singular Genomics Systems Company Profile

Singular Genomics Systems, Inc, a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue.